2Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radia- tion Therapy Oncology Group 94-05 ) phase m trial of com- bined-modality therapy for esophageal cancer: high-dose ver- sus. standard-dose radiation therapy. J Clin Oncol, 2002, 20 (5):1167-1174. 被引量：1
3Medica IR Esearch Council Esophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in e- sophageal cancer ： a randomised contro lledtrial. Lancet, 2002,359(9319) .. 1727-1733. 被引量：1
4Kelley ST, Coppola D, Karl RC. Neoadjuvant chemoradio- therapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gas- trointest Surg, 2004, 8(3): 227-232. 被引量：1
5Mariette C, Fahre S, Balon JM, et al. Patients surviving 5years after curative oesophagectomy for oesophageal cancer. Ann Chir, 2003, 128.. 536-542. 被引量：1
二级参考文献5
1D′Ugo,Persiani R,Pende V,et al.Neoadjuvant Chemotherapy in gastri c carcinoma.Ann Ital Chir,2001,72(1):47～53. 被引量：1
2Schuhmacher CP,Fink U,Becker K,et al.Neoadjuvant therapy for pa tients w ith locally advanced gastric carcinoma with etoposide,doxorubicin,and cisplati num.Closing results after 5 years of follow-up.Cancer,2001,91(5):918.[ ZK)〗 被引量：1
3Cascinu S,Graziano F,Barbi S,et al.A phase 2 stage of sequent ial chemot herapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Itally group for the study of digestive tract cancer.Br J Ca ncer,2001,84(4):470～474. 被引量：1
8HYNGSTROM JR, POSNER MC. Neoadjuvant strategies for the treatment of locally advanced esophageal cancer [ J ]. J Surg Oncol,2010,101 (4) :299 -304. 被引量：1
9SUTO Y,TOMIZAWA N, ANDOH T, et al. A case of Barrett's esophageal carcinoma treated with combined therapy [ J ]. Gan To Kagaku Ryoho,2012,39 ( 12 ) :2110 - 2112. 被引量：1
10Hyngstrom JR, Posner MC. Neoadjuvant strategies for the treatment of locally advanced esophageal cancer E J]. J Surg Oncol, 2010,101(4) : 299 304. 被引量：1
